NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GeneSpark Diagnostics

GeneSpark Diagnostics

Private
Branford, ConnecticutHealthcare & Life Scienceshttps://genesparkdiagnostics.com/

Last Round

Series B

Aug 6, 2020

Total Funding Raised

$28.4M

Company Overview

GeneSpark Diagnostics is a molecular diagnostics company that develops rapid, portable, and point-of-care diagnostic platforms for infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Environmental Monitoring

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

molecular diagnosticsisothermal amplificationpoint-of-care testingPOCTdiagnostic assaysLAMP assayrapid testinginfectious disease testinglab-on-a-chipdiagnostic hardwareLIMS integrationAMR testingportable diagnosticsclinical diagnosticsveterinary diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneSpark Diagnostics Comparables

Compare GeneSpark Diagnostics with similar companies based on industry and business-model similarity.

GeneSpark Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
U Star Biochemical Technologies, Inc.
80%
binx health
77%
Danaher Corporation
77%

GeneSpark Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 6, 2020
GrantJun 29, 2020
GrantMay 5, 2020
GrantApr 20, 2020
Series AJun 20, 2019
Grant
Nov 20, 2017

GeneSpark Diagnostics Investors

Notable investors and investment history

GeneSpark Diagnostics investors
InvestorRounds
VC23 InvestorsSeries B, Series A
Connecticut InnovationsSeries B, Series A
Parvizi Surgical InnovationSeries B
Public Health Emergency Medical Countermeasures EnterpriseGrant
Leading Edge VenturesSeries B, Series A

GeneSpark Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GeneSpark Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GeneSpark Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBranford, Connecticut
Year Founded2013
Last FundingAug 6, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.